Colchicine in COVID-19: a Pilot Study

NCT04375202 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

227

Enrollment

OTHER

Sponsor class

Stopped Insufficient rate of patient accrual and newly available scientific evidence

Conditions

COVID-19

Interventions

DRUG: Colchicine 1 MG Oral Tablet

Sponsor

University Of Perugia